(2R,4R)-1-Tert-Butyl2-(2-(9-((2S,5S)-1-((S)-2-(Methoxycarbonylamino)-3-Methylbutanoyl)-5-Methylpyrrolidine-2-Carbonyloxy)-8-Oxo-8,9,10,11-Tetrahydro-5H-Dibenzo[C,G]Chromen-3-Yl)-2-Oxoethyl)4-(Methoxymethyl)Pyrrolidine-1,2-Dicarboxylate

The full IUPAC-designated molecule (2R,4R)-1-tert-butyl 2-(2-(9-((2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carbonyloxy)-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl)-2-oxoethyl) 4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate, empirical formula C₄₁H₄₉N₃O₁₃ and monoisotopic mass 815.3265 Da, is offered exclusively as a chiral, non-GMP research intermediate for the construction of protease-responsive molecular architectures. The product is supplied as a lyophilised off-white to pale yellow powder with a chromatographic purity of ≥95% (HPLC, 254 nm). Residual water content, determined by coulometric Karl Fischer titration according to USP <921>, is routinely ≤1.0% w/w. Each manufacturing lot is accompanied by a comprehensive certificate of analysis that includes full ¹H and ¹³C NMR assignment (DMSO-d₆, 400 MHz), HRMS confirmation via ESI-TOF (mass accuracy ≤3 ppm), and chiral HPLC purity from a Chiralpak IA-3 column (heptane/ethanol/0.1% TFA) reporting an enantiomeric excess ≥98%. The material has not been assigned a CAS registry number and is not manufactured under ICH Q7 GMP; it is intended solely for preclinical discovery and process research.

What Distinguishes the Stereochemical Architecture of This Dibenzo[c,g]chromen-Pyrrolidine Conjugate?

The compound is built around the 8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen scaffold, a rigid tetracyclic framework that defines the spatial presentation of the appended peptide-mimetic side chains. Four isolated stereocenters are locked in predetermined absolute configurations: the (2R,4R) geometry of the pyrrolidine-1,2-dicarboxylate segment bearing the tert-butyl and 2-oxoethyl ester groups, and the (2S,5S) arrangement of the 5-methylpyrrolidine-2-carbonyloxy tether derived from a substituted proline analog. The N-terminus is capped as the (S)-2-(methoxycarbonylamino)-3-methylbutanoyl moiety, a carbamate-protected L-valine equivalent. This stereochemical rigour is not incidental: the 4-(methoxymethyl) substituent on the (2R,4R)-pyrrolidine ring introduces an additional hydrogen-bond-accepting side chain whose orientation is fixed relative to the chromen plane, while the tert-butyl ester furnishes a sterically demanding protecting group orthogonal to the methoxycarbonyl and methyl ester functionalities. Solution-state ¹H NMR data show distinct doubling of the diastereotopic methylene protons adjacent to the 8-oxo group, consistent with slow conformational interconversion of the tetrahydrodibenzo chromen ring system on the NMR timescale.

Shipment under uncontrolled ambient conditions does not compromise the integrity of the lyophilisate; however, upon receipt the material should be transferred to a desiccator and placed under an inert atmosphere at −20 °C within 48 hours. The tert-butyl ester protecting group displays pronounced acid lability: exposure to trifluoroacetic acid concentrations exceeding 1% v/v in dichloromethane leads to complete deprotection within 30 min at room temperature, as monitored by TLC (Rf shift from 0.45 to 0.10 in EtOAc/hexane 1:1). Conversely, the methoxycarbonylamino functionality remains intact under these acidic conditions but can be cleaved by esterases or specific serine proteases, a duality that permits sequential orthogonal deprotection of the C- and N-terminal blocking groups. All aliquoting should be performed in a moisture-controlled environment (<30% RH) to prevent premature hydrolysis of the 2-oxoethyl ester linkage connecting the chromen ring to the pyrrolidine core; a molecular sieve (4 Å) is recommended as an in-vial desiccant for solutions stored longer than 72 h.

Storage, Stability, and Degradation Pathways

Forced degradation studies conducted at 40 °C/75% RH over 14 days identify the 8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen ester junction as the primary hydrolytically labile site. Cleavage at this position liberates the (2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid fragment and a phenol-type chromen derivative detectable by LC-MS at m/z 403.1. A secondary degradation route, observed only in the presence of trace metal ions (Fe³⁺ ≥0.5 ppm), involves oxidative opening of the tetrahydrodibenzo ring producing a quinone methide intermediate that rapidly oligomerises. For this reason, vials are packaged under reduced-oxygen headspace (<2% O₂) and metal-chelating closures are employed. Long-term stability data under the recommended storage condition indicate ≤2% assay loss over 24 months, with no detectable epimerisation at any of the four stereocenters by chiral HPLC. When dissolved in anhydrous DMF and stored under argon at −20 °C, the compound is stable for at least 4 weeks; however, repeated freeze-thaw cycles should be avoided as they promote water condensation and concomitant ester hydrolysis.

Probing Protease Selectivity with a Non-Self-Immolative Chromen Ester Scaffold

In the context of cleavable linker chemistry, the title compound replaces the traditional p-aminobenzyl alcohol (PAB) self-immolative spacer with a fused dibenzo[c,g]chromen framework. While PAB-based systems undergo spontaneous 1,6-elimination upon dipeptide cleavage to liberate the payload, this construct relies on direct enzymatic hydrolysis of the ester bond between the chromen 3-position and the valine-proline dipeptide surrogate. The consequence is a release mechanism that is entirely enzyme-driven, eliminating the background hydrolysis associated with the self-immolative cascade. The N-methoxycarbonyl-Val-(2S,5S)-Pro motif was selected because cathepsin B, a cysteine protease overexpressed in multiple tumour types, accepts N-protected Val-Xaa dipeptides where Xaa is a proline or other constrained amino acid, albeit with a k_cat/K_M value that differs from the canonical Val-Cit sequence. Published data for closely related N-carbamoyl-Val-Pro esters indicate an acylation half-life in the order of minutes to hours at pH 5.0, modulated by the electronic character of the ester leaving group; the 8-oxo substituent withdraws electron density through the extended π-system, thereby lowering the pKₐ of the departing chromen hydroxyl and potentially accelerating the rate-limiting acylation step. Researchers deploying this compound are therefore advised to benchmark cleavage kinetics against a Val-Cit-PAB reference substrate using recombinant cathepsin B (specific activity ≥500 pmol/min/µg) in MES buffer at pH 5.0 containing DTT as a reducing agent.

The dibenzo[c,g]chromen core additionally confers a significant UV absorption band (λ_max 312 nm, ε ≈ 18,000 M⁻¹cm⁻¹) that simplifies HPLC-based monitoring of payload release without requiring the attachment of a fluorescent reporter. The 4-methoxymethyl substituent on the pyrrolidine diester segment does not participate in the cleavage event but can serve as a convenient ¹H NMR handle (singlet at δ 3.25) for quantifying intact conjugate in biological matrices. It is not, however, a bioorthogonal reactive handle, and strategies that seek to functionalise this site through oxidation or displacement must contend with the neighbouring methyl ester, which undergoes slow saponification at pH values exceeding 8.5.

This direct comparison makes plain that the dibenzo[c,g]chromen-pyrrolidine conjugate occupies a niche between traditional self-immolative linkers and enzymatically labile ester prodrugs. The absence of an aniline-based PAB unit eliminates the risk of mutagenic degradation products that must be controlled under ICH M7, while the rigid chromen fluorophore allows label-free quantitation in cathepsin activity assays. On the other hand, the lack of a self-immolative step means that the payload—here, the 8-oxo-tetrahydrodibenzo chromen itself—must be connected through a bond that is directly susceptible to the activating protease, limiting the strategy to conjugates where the core scaffold is intended to be the active species or where further elaboration can be tolerated. Synthetic manipulation of the free phenol obtained after enzymatic cleavage is feasible through Mitsunobu etherification or sulfonylation, though the yield is substantially influenced by the bulk of the 4-methoxymethylpyrrolidine portion still attached via the 2-oxoethyl tether.

Operationally, users originating solid-phase peptide synthesis (SPPS) protocols should note that the methoxycarbonylamino group is not orthogonal to the Fmoc strategy; consequently, the compound is more readily integrated into Boc-SPPS or solution-phase fragment couplings. The tert-butyl ester is selectively removed with TFA cocktails containing triisopropylsilane and water, leaving the methoxycarbonyl and methyl ester intact. Subsequent coupling to a polymer carrier via the liberated carboxylic acid has been demonstrated on H-Cys(Trityl)-2-Cl-Trt resin using HATU/DIEA activation, enabling direct comparison with on-resin Val-Cit-PAB constructions. When substitution of the Val-Pro dipeptide for the canonical Val-Cit is contemplated, the shift in cathepsin B S2 subsite occupancy must be evaluated by molecular modelling; the proline pyrrolidine ring occupies a volume of 62.4 ų versus 109.8 ų for citrulline, conferring a different shape complementarity that may reduce off-target cleavage by cathepsin L while preserving responsiveness in high-cathepsin-B microenvironments.